Orient Pharma Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was TWD 182.006 million compared to TWD 167.253 million a year ago. Operating loss was TWD 106.771 million compared to TWD 74.873 million a year ago. Net loss was TWD 61.766 million compared to TWD 59.939 million a year ago. Basic loss per share was TWD 0.33 compared to TWD 0.38 a year ago.